+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Diphtheria Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767617
  • Report
  • 169 pages
  • VPA Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Cadila Healthcare Ltd
  • GlaxoSmithKline Plc
  • LG Life Science LTD
  • Merck & Co Inc
  • Novartis AG
  • Panacea Biotec Ltd
  • MORE
The global clinical trial report- “2019 Diphtheria Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Diphtheria. It presents in-depth analysis of Diphtheria clinical trials across markets and companies. The research work is for providing complete understanding into trends in Diphtheria.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Diphtheria clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Diphtheria

The research work is prepared through extensive and continuous research on Diphtheria trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Diphtheria patients are identified
  • The report includes panorama of Diphtheria clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Diphtheria clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Cadila Healthcare Ltd
  • GlaxoSmithKline Plc
  • LG Life Science LTD
  • Merck & Co Inc
  • Novartis AG
  • Panacea Biotec Ltd
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Diphtheria Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Diphtheria Clinical Trials by Region
2.2.2 Average Enrollment of Diphtheria Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Diphtheria Treatment, 2019

3. Region wise Diphtheria Clinical Trials
3.1 Asia Pacific Diphtheria Clinical Trials by Country
3.2 Europe Diphtheria Clinical Trials by Country
3.3 North America Diphtheria Clinical Trials by Country
3.4 Middle East and Africa Diphtheria Clinical Trials by Country
3.5 South and Central America Diphtheria Clinical Trials by Country

4. Diphtheria Clinical Trial Trends
4.1 Start Year wise Diphtheria Clinical Trials
4.2 Phase wise Diphtheria Clinical Trials
4.3 Trial Status wise Diphtheria Clinical Trials
4.4 Trial Type wise Diphtheria Clinical Trials

5. Diphtheria Average Enrollment Trends
5.1 Average Enrollment in Diphtheria Trials by Year
5.2 Average Enrollment in Diphtheria Trials by Phase
5.3 Average Enrollment in Diphtheria Trials by Status
5.4 Average Enrollment in Diphtheria Trials by Type of Trial

6. Companies Participating in Diphtheria Clinical Trials
6.1 Diphtheria Trials by Sponsor Type
6.2 Diphtheria Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Diphtheria Trials- Phase 1
7.2 Diphtheria Trials- Phase 2
7.3 Diphtheria Trials- Phase 3
7.4 Diphtheria Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Diphtheria Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Diphtheria Clinical Trials and Enrolment
Figure 5: Europe - Country wise Diphtheria Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Diphtheria Clinical Trials and Enrolment
Figure 7: North America - Country wise Diphtheria Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Diphtheria Clinical Trials and Enrolment
Figure 9: Diphtheria Clinical Trials by Phase
Figure 10: Diphtheria Clinical Trials by Trial Status
Figure 11: Diphtheria Clinical Trials by Type
Figure 12: Diphtheria Clinical Trials by Sponsor Type
Figure 13: Diphtheria Clinical Trials by Leading Sponsors
Figure 14: Diphtheria Average Enrollment by Phase
Figure 15: Diphtheria Average Enrollment by Trial Status
Figure 16: Diphtheria Average Enrollment by Type
Figure 17: Diphtheria- Average Enrolment by Type of Sponsors
Figure 18: Diphtheria- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Diphtheria Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Diphtheria Clinical Trials and Enrolment
Table 5: Europe - Country wise Diphtheria Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Diphtheria Clinical Trials and Enrolment
Table 7: North America - Country wise Diphtheria Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Diphtheria Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Diphtheria Average Enrollment by Phase
Table 15: Diphtheria Average Enrollment by Trial Status
Table 16: Diphtheria Average Enrollment by Type
Table 17: Diphtheria- Average Enrolment by Type of Sponsors
Table 18: Diphtheria- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Cadila Healthcare Ltd
  • GlaxoSmithKline Plc
  • LG Life Science LTD
  • Merck & Co Inc
  • Novartis AG
  • Panacea Biotec Ltd
  • PT Bio Farma
  • Sanofi
  • Sanofi Pasteur MSD SNC
  • Serum Institute of India Ltd
Note: Product cover images may vary from those shown
Adroll
adroll